Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates

Posted: September 2, 2024 at 2:53 am

SHANGHAI, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2024 interim financial results and provided corporate updates.

Read more here:
Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates

Related Posts